The Ayush Valley Foundation in association
with the Ayurveda & Health Tourism Magazine will organise a webinar on ‘Ayurveda
Medicine Manufacturing: Challenges and Opportunities post Covid-19’ on
September 26.
The nearly two-hour session, as part
of the National Webinar Series ‘AYUSHVICHAR’, will be attended by experts in
the field including Dr Hrishikesh Damle, MD & CEO, Atrimed Pharmaceuticals
(P) Ltd, Dr S Sajikumar, Managing Director, Dhatri Ayurveda (P) Ltd and Dr
Narasimham Jammi, CEO, Jammi Pharmaceuticals. The webinar will be
moderated by Dr Madan Thangavelu, noted Genome Biologist from the University of
Cambridge, UK, and co-moderated by Dr Harikumar Bhaskaran Nair, Ayurvedic
Physician, Research and Co-ordinator, NSS Ayurvedic Hospitals.
The Indian Ayurveda Industry is still
lagging though the ancient healing system is increasingly being accepted,
thanks to the immunity boosting properties and the holistic approach of treatment.
While India is fast turning out to be the global hub of medicinal
manufacturing, the local Ayurveda pharmaceutical market is just 10 per cent of
its Allopathic counterpart, estimated to be around USD 20 billion. The same
presents both opportunities and challenges.
The experts will discuss the topic in
detail and also the future opportunities in the segment during the virtual
section which will commence at 4.30 IST on Saturday. For further details, log
into http://www.ayushvalley.org/ .
The first of the National Webinar
series on the topic ‘Validation and Documentation in Ayurveda’, held on August 22, evoked sharp
response. Dr D C
Katoch, Joint Advisor, Indian Ministry of Ayush, enumerated the various measures
taken by the government for development of Ayurveda, including standardisation,
formation of essentiDr S Sajikumaral drugs list and extension of insurance coverage.
